WallStreetZenWallStreetZen

NASDAQ: ENTA
Enanta Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ENTA

Based on 1 analyst offering 12 month price targets for Enanta Pharmaceuticals Inc

Min Forecast
$20.00+78.57%
Avg Forecast
$20.00+78.57%
Max Forecast
$20.00+78.57%

Should I buy or sell ENTA stock?

Based on 1 analyst offering ratings for Enanta Pharmaceuticals Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ENTA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ENTA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their ENTA stock forecasts and price targets.

ENTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-23

1 of 1

Forecast return on equity

Is ENTA forecast to generate an efficient return?

Company
-89.65%
Industry
19.54%
Market
161.2%
ENTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENTA forecast to generate an efficient return on assets?

Company
-30.52%
Industry
19.93%
ENTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENTA earnings per share forecast

What is ENTA's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$2.39
Avg 2 year Forecast
-$2.98
Avg 3 year Forecast
-$3.11

ENTA revenue forecast

What is ENTA's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$58.9M-9.77%
Avg 2 year Forecast
$54.6M-16.38%
Avg 3 year Forecast
$98.6M+51.13%
ENTA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ENTA revenue growth forecast

How is ENTA forecast to perform vs Biotechnology companies and vs the US market?

Company
10.91%
Industry
31.51%
Market
12.32%
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ENTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTA$11.20$20.00+78.57%Buy
EIKN$6.04$13.50+123.51%Hold
MPLT$7.07$32.78+363.62%Buy
XFOR$3.17$11.50+262.78%Strong Buy
EDIT$2.14$5.50+157.01%Strong Buy
View Top Biotech Stocks

Enanta Pharmaceuticals Stock Forecast FAQ

Is Enanta Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ENTA) stock is to Buy ENTA stock.

Out of 1 analyst, 0 (0%) are recommending ENTA as a Strong Buy, 1 (100%) are recommending ENTA as a Buy, 0 (0%) are recommending ENTA as a Hold, 0 (0%) are recommending ENTA as a Sell, and 0 (0%) are recommending ENTA as a Strong Sell.

If you're new to stock investing, here's how to buy Enanta Pharmaceuticals stock.

What is ENTA's earnings growth forecast for 2027-2029?

(NASDAQ: ENTA) Enanta Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.85%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.79%.

Enanta Pharmaceuticals's earnings in 2026 is -$63,230,000.On average, 7 Wall Street analysts forecast ENTA's earnings for 2027 to be -$69,714,562, with the lowest ENTA earnings forecast at -$75,924,098, and the highest ENTA earnings forecast at -$62,386,611. On average, 6 Wall Street analysts forecast ENTA's earnings for 2028 to be -$86,747,097, with the lowest ENTA earnings forecast at -$96,189,553, and the highest ENTA earnings forecast at -$75,536,730.

In 2029, ENTA is forecast to generate -$90,609,126 in earnings, with the lowest earnings forecast at -$101,327,274 and the highest earnings forecast at -$77,983,264.

What is ENTA's revenue growth forecast for 2027-2029?

(NASDAQ: ENTA) Enanta Pharmaceuticals's forecast annual revenue growth rate of 10.91% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.32%.

Enanta Pharmaceuticals's revenue in 2026 is $65,258,000.On average, 7 Wall Street analysts forecast ENTA's revenue for 2027 to be $1,715,049,297, with the lowest ENTA revenue forecast at $1,518,190,705, and the highest ENTA revenue forecast at $1,957,227,014. On average, 6 Wall Street analysts forecast ENTA's revenue for 2028 to be $1,589,373,187, with the lowest ENTA revenue forecast at $1,427,144,698, and the highest ENTA revenue forecast at $1,743,155,310.

In 2029, ENTA is forecast to generate $2,872,521,898 in revenue, with the lowest revenue forecast at $1,315,827,412 and the highest revenue forecast at $5,168,302,585.

What is ENTA's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: ENTA) forecast ROA is -30.52%, which is lower than the forecast US Biotechnology industry average of 19.93%.

What is ENTA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ENTA price target, the average ENTA price target is $20.00, with the highest ENTA stock price forecast at $20.00 and the lowest ENTA stock price forecast at $20.00.

The Wall Street analyst predicted that Enanta Pharmaceuticals's share price could reach $20.00 by Sep 23, 2027. The average Enanta Pharmaceuticals stock price prediction forecasts a potential upside of 78.57% from the current ENTA share price of $11.20.

What is ENTA's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: ENTA) Enanta Pharmaceuticals's current Earnings Per Share (EPS) is -$2.42. On average, analysts forecast that ENTA's EPS will be -$2.39 for 2027, with the lowest EPS forecast at -$2.61, and the highest EPS forecast at -$2.14. On average, analysts forecast that ENTA's EPS will be -$2.98 for 2028, with the lowest EPS forecast at -$3.30, and the highest EPS forecast at -$2.59. In 2029, ENTA's EPS is forecast to hit -$3.11 (min: -$3.48, max: -$2.68).

What is ENTA's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: ENTA) forecast ROE is -89.65%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.